SQZ BIOTECHNOLOGIES COMPANY Restructuring Charges
SQZ BIOTECHNOLOGIES COMPANY reported Restructuring Charges of $7.68 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2023-11-08
- SQZ BIOTECHNOLOGIES COMPANY restructuring charges for the quarter ending 2023-09-30 was $7.68M.
- SQZ BIOTECHNOLOGIES COMPANY restructuring charges for the quarter ending 2023-06-30 was $0.00.
- SQZ BIOTECHNOLOGIES COMPANY restructuring charges for the quarter ending 2023-03-31 was -$7.00K.
- SQZ BIOTECHNOLOGIES COMPANY restructuring charges for fiscal 2022 was $4.86M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2023-09-30 | $7.68M 10-Q · filed 2023-11-08 | $7.68M derived: sum of 2 quarters · filed 2023-11-08 | $7.57M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$7.00K 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | -$7.00K 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | $4.86M 10-K · filed 2023-03-22 |